Condition: Primary Membranous Nephropathy · Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd
To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy
This description comes directly from the study's public registry record.
Minghui Zhao · 0086- 010-66119025 · bdyyec@163.com
Always discuss trial participation with your own doctor first.
| Beijing Tsinghua Changgung Hospital | Beijing, China | Recruiting |
| Peking university first hospital | Beijing, China | Recruiting |
| The Second Norman Bethune Hospital of Jilin University | Changchun, China | Recruiting |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, China | Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou, China | Recruiting |
| Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Shandong Provincial Hospital | Jinan, China | Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, China | Recruiting |
| Affiliated Hospital of Nantong University | Nantong, China | Recruiting |
| The Affiliated Hospital of Qingdao University | Qingdao, China | Recruiting |
| Northern Theater Command General Hospital | Shenyang, China | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06470191